True Link Financial Advisors, LLC Merck & Co., Inc. Transaction History

True Link Financial Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$123.8 - $132.96 $226,554 - $243,316	1,830 New	1,830 $226,000
Q3 2023 Oct 30, 2023	BUY	$102.95 - $114.33 $31,090 - $34,527	302 Added 9.9%	3,352 $345,000
Q3 2022 Nov 09, 2022	BUY	$84.53 - $94.96 $257,816 - $289,628	3,050 New	3,050 $263,000
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $84,536 - $94,760	-1,150 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$72.28 - $90.54 $13,154 - $16,478	-182 Reduced 13.66%	1,150 $88,000
Q3 2021 Oct 29, 2021	SELL	$71.68 - $78.83 $14,336 - $15,766	-200 Reduced 13.05%	1,332 $100,000
Q2 2021 Aug 19, 2021	BUY	$70.31 - $77.77 $12,796 - $14,154	182 Added 13.48%	1,532 $119,000
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $13,772 - $16,222	200 Added 17.39%	1,350 $104,000
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $82,535 - $91,597	1,150 New	1,150 $94,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of True Link Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on True Link Financial Advisors, LLC with notifications on news.